These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20853123)

  • 1. The binding properties of the H5N1 influenza virus neuraminidase as inferred from molecular modeling.
    Raab M; Tvaroška I
    J Mol Model; 2011 Jun; 17(6):1445-56. PubMed ID: 20853123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N1 neuraminidase of H5N1 avian influenza A virus complexed with sialic acid and zanamivir - A study by molecular docking and molecular dynamics simulation.
    Jeyaram RA; Anu Radha C
    J Biomol Struct Dyn; 2022; 40(21):11434-11447. PubMed ID: 34369311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan binding and specificity of viral influenza neuraminidases by classical molecular dynamics and replica exchange molecular dynamics simulations.
    Phanich J; Threeracheep S; Kungwan N; Rungrotmongkol T; Hannongbua S
    J Biomol Struct Dyn; 2019 Aug; 37(13):3354-3365. PubMed ID: 30126341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
    Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tetramerization on the ligand recognition of N1 influenza neuraminidase via MMGBSA approach.
    Bello M
    Biopolymers; 2019 May; 110(5):e23251. PubMed ID: 30589081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance.
    Garcia JM; Lai JC; Haselhorst T; Choy KT; Yen HL; Peiris JS; von Itzstein M; Nicholls JM
    Influenza Other Respir Viruses; 2014 Mar; 8(2):235-42. PubMed ID: 24118862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ; Du QS; Sun H; Chou KC
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.
    Wang P; Zhang JZ
    J Phys Chem B; 2010 Oct; 114(40):12958-64. PubMed ID: 20860351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy.
    Lawrenz M; Wereszczynski J; Amaro R; Walker R; Roitberg A; McCammon JA
    Proteins; 2010 Aug; 78(11):2523-32. PubMed ID: 20602360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase.
    Jongkon N; Sangma C
    J Mol Model; 2012 Jan; 18(1):285-93. PubMed ID: 21523534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW; Jo WH
    Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble.
    Landon MR; Amaro RE; Baron R; Ngan CH; Ozonoff D; McCammon JA; Vajda S
    Chem Biol Drug Des; 2008 Feb; 71(2):106-16. PubMed ID: 18205727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of fluorinated sialic acid analog inhibitor to H5 hemagglutinin of H5N1 influenza virus through molecular dynamics simulation study.
    Jeyaram RA; Radha CA; Gromiha MM; Veluraja K
    J Biomol Struct Dyn; 2020 Aug; 38(12):3504-3513. PubMed ID: 31594458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.